geha glp-1 coverage MCT2D Navigating Changes to GLP-1 Medication

[DOI] [PMC free article] [PubMed] [Google Scholar] 17.Jastreboff A

For SELECT, researchers analyzed data from 17,604 adults aged 45 years or older with overweight or obesity and established CVD but without diabetes, randomly assigned once-weekly semaglutide 2.4 mg or placebo, with follow-up for 5 years, according to a press release from Novo Nordisk

While this study was observational i.e., participants were not randomly assigned to one medication or the other the study used a complex weighting strategy to control for many variables that might influence the relationship between mediation prescription and substance use outcomes

Online Orders How effective is GLP-1 for Weight Loss

Visceral fatthe metabolically active adipose tissue surrounding internal organsposes greater health risks than subcutaneous fat, driving insulin resistance, cardiovascular disease, and metabolic dysfunction

Appetite control and craving reduction Cravings and increased hunger often make postpartum weight loss difficult